How Much Did DFB Pharmaceuticals Raise?
Funding & Key Investors

DFB Pharmaceuticals has solidified its market position through a significant capital infusion, bringing its total funding to $150K. This latest injection of $150K represents a major strategic investment aimed at accelerating the firm's operational capabilities and expanding its footprint within the competitive life sciences sector. By securing this financing, the organization reinforces its commitment to scaling high-impact healthcare solutions through a disciplined, acquisition-led growth strategy.

What is DFB Pharmaceuticals?

DFB Pharmaceuticals
Holding Companies & Conglomerates

DFB Pharmaceuticals operates as a sophisticated private investment and management entity, uniquely positioned at the intersection of healthcare innovation and operational management. The firm distinguishes itself by cultivating a portfolio of specialized subsidiaries, most notably NanOlogy, which pioneers targeted cancer therapies, and Phyton Biotech, a leader in plant cell fermentation technology for pharmaceutical applications. By leveraging a model that combines strategic acquisitions with rigorous product development, DFB Pharmaceuticals effectively bridges the gap between early-stage research and commercial-scale healthcare delivery. Its focus on operational excellence ensures that its subsidiaries maintain the agility required to navigate complex regulatory environments while delivering tangible advancements in patient care and therapeutic efficacy.

How much funding has DFB Pharmaceuticals raised?

DFB Pharmaceuticals has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in DFB Pharmaceuticals

PPP

Public-Private Partnership

What's next for DFB Pharmaceuticals?

With the successful procurement of this late-stage capital, DFB Pharmaceuticals is well-positioned to execute its next phase of corporate expansion. The strategic roadmap likely involves deepening the commercialization efforts of its existing subsidiaries and potentially identifying new acquisition targets that align with its core mission of enhancing healthcare technologies. As the firm continues to integrate its diverse portfolio, the focus will remain on optimizing the value chain of its life science operations. Investors and industry observers will be monitoring how this influx of resources translates into accelerated clinical milestones and broader market penetration for its proprietary therapeutic platforms, further cementing the company's role as a pivotal player in the evolution of modern pharmaceutical development.

See full DFB Pharmaceuticals company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Holding Companies & Conglomerates industry

Holding Companies & Conglomerates
Holding Companies & ConglomeratesBusiness ServicesEducationProject ManagementTraining
Holding Companies & Conglomerates
Holding Companies & ConglomeratesManufacturingIndustrial Machinery & Equipment

Frequently Asked Questions Regarding DFB Pharmaceuticals Financial Insights

What are the most recent funding rounds that DFB Pharmaceuticals has completed, and what were the funding rounds?
DFB Pharmaceuticals has recently completed 1 funding rounds: Debt on Apr 30, 2020.
What is the total amount of funding DFB Pharmaceuticals has raised to date?
DFB Pharmaceuticals has raised a total of $150K in funding to date.
How many funding rounds has DFB Pharmaceuticals completed?
DFB Pharmaceuticals has completed 1 funding rounds.
How much funding did DFB Pharmaceuticals raise in its most recent funding round?
DFB Pharmaceuticals raised $150K in its most recent funding round.
Who are the lead investors in DFB Pharmaceuticals's latest funding round?
The lead investor in DFB Pharmaceuticals's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in DFB Pharmaceuticals's history?
The largest funding round in DFB Pharmaceuticals's history was $150K.
See more information about DFB Pharmaceuticals